Adrian Ridge zum CEO der Nikkiso Clean Energy & Industrial Gases Group ernannt

TEMECULA, Kalifornien, July 02, 2024 (GLOBE NEWSWIRE) — Seit dem 1. Juli 2024 ist Adrian Ridge Chief Executive Officer der Nikkiso Clean Energy & Industrial Gases Group, die zur Industrieabteilung von Nikkiso Co. Ltd. gehört. Ridge tritt die Nachfolge von Peter Wagner an, welcher weiterhin im Verwaltungsrat der Nikkiso CE&IG Group als Executive Chairman tätig sein wird.

Als CEO wird Ridge die operativen und finanziellen Ergebnisse vorantreiben und die Gruppe für zukünftiges Wachstum vorbereiten. In seiner neuen Rolle als Executive Chairman wird Wagner sich darauf konzentrieren, die Vision und die langfristige Strategie der Gruppe in einer beratenden Funktion mitzugestalten.

„Im Namen des Verwaltungsrats heiße ich Adrian willkommen und gratuliere ihm zu seiner Beförderung zum CEO“, verkündet Wagner. „Er ist eine bewährte Führungskraft, die sich zum richtigen Zeitpunkt engagiert, um das Wachstum von Nikkiso Clean Energy & Industrial Gases zu neuen Höhen zu führen.“

„Noch nie hat mich das Potenzial eines Unternehmens so begeistert wie jenes von Nikkiso“, so Ridge. „Wir haben alle Voraussetzungen, um in jedem Markt, den wir bedienen, in jeder Region der Welt führend zu sein. Ich fühle mich geehrt und bin dankbar für diese einmalige Gelegenheit.“

Über Adrian Ridge

Ridge kam 2022 als EVP of Manufacturing and Operations zu Nikkiso Clean Energy & Industrial Gases, nachdem er rund 30 Jahre in verschiedenen globalen Führungspositionen beim schwedischen Fertigungsriesen Atlas Copco tätig war. Er hat einen Abschluss in Maschinenbau und einen MBA von der Durham University in Großbritannien.

Medienkontakt
Lisa Adams
[email protected]
Mobil: +1 (405) 492–1689

Über die Nikkiso Clean Energy & Industrial Gases Group

Die Nikkiso Clean Energy & Industrial Gases Group ist ein führender Anbieter von kryogenen Anlagen, Technologien und Anwendungen für die Marktsegmente saubere Energie und Industriegase. Die Gruppe beschäftigt mehr als 1.600 Mitarbeitende in 22 Ländern und wird von Cryogenic Industries, Inc. in Südkalifornien, USA, geleitet, einer hundertprozentigen Tochtergesellschaft von Nikkiso Co., Ltd. (TSE: 6376).

Ein Foto zu dieser Ankündigung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/b3496ba9–85d1–4c91–b199–181d30747a25


GLOBENEWSWIRE (Distribution ID 9172603)

Adrian Ridge est nommé directeur général de Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Californie, 02 juill. 2024 (GLOBE NEWSWIRE) — À compter du 1er juillet 2024, Adrian Ridge est directeur général de Nikkiso Clean Energy & Industrial Gases Group, qui fait partie de la branche industrielle de Nikkiso Co. Ltd. Ridge succède à Peter Wagner, qui reste engagé au sein du conseil d’administration en tant que président exécutif de Nikkiso CE&IG Group.

En tant que directeur général, Ridge pilotera les performances opérationnelles et financières du Groupe et le préparera à sa croissance future. Dans son rôle de président exécutif, Wagner se concentrera sur la mise en œuvre de la vision et de la stratégie à long terme du Groupe en qualité de conseiller.

« Au nom du conseil d’administration, je souhaite la bienvenue et félicite Adrian pour sa promotion au poste de directeur général », a déclaré Wagner. « C’est un leader confirmé qui s’engage au bon moment pour soutenir la croissance de Nikkiso Clean Energy & Industrial Gases vers de nouveaux sommets. »

« Je n’ai jamais été aussi enthousiasmé par le potentiel d’une entreprise que par celui de Nikkiso », a affirmé Ridge. « Nous disposons de tous les ingrédients nécessaires pour être leader sur tous les marchés que nous desservons dans toutes les régions du monde. Je suis honoré et reconnaissant pour cette opportunité unique. »

À propos d’Adrian Ridge

Ridge a rejoint Nikkiso Clean Energy & Industrial Gases en 2022 en tant que vice–président directeur de la fabrication et des opérations après avoir travaillé près de 30 ans chez le géant manufacturier suédois Atlas Copco où il a occupé plusieurs postes de direction au niveau mondial. Il est titulaire d’un diplôme en génie mécanique et d’un MBA de l’Université de Durham au Royaume–Uni.

Contact média
Lisa Adams
[email protected]
Mobile : +1 405 492–1689

À propos de Nikkiso Clean Energy & Industrial Gases Group

Nikkiso Clean Energy & Industrial Gases Group est un fournisseur leader d’équipements cryogéniques et de technologies et d’applications conçues pour les marchés inhérents à l’énergie propre et aux gaz industriels. Le Groupe emploie plus de 1 600 personnes dans 22 pays sous la direction de Cryogenic Industries, Inc. en Californie du Sud, aux États–Unis, qui est une filiale à 100 % de Nikkiso Co., Ltd. (TSE: 6376).

Une photo accompagnant cette annonce est disponible sur https://www.globenewswire.com/NewsRoom/AttachmentNg/b3496ba9–85d1–4c91–b199–181d30747a25


GLOBENEWSWIRE (Distribution ID 9172603)

Adrian Ridge nomeado CEO do Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Califórnia, July 02, 2024 (GLOBE NEWSWIRE) — A partir de 1 de julho de 2024, Adrian Ridge é o CEO do Nikkiso Clean Energy & Industrial Gases Group, parte da divisão industrial da Nikkiso Co. Ltd. Ridge sucede a Peter Wagner, que continua a desempenhar funções no Conselho de Administração como Executive Chairman do Nikkiso CE&IG Group.

Enquanto CEO, Ridge irá impulsionar os resultados operacionais e financeiros e preparar o Grupo para o crescimento futuro. Na sua função de Executive Chairman, Wagner concentrar–se–á na condução da visão e da estratégia a longo prazo do Grupo, na qualidade de consultor.

“Em nome do Conselho de Administração, dou as boas–vindas e felicito Adrian pela sua promoção a CEO”, afirmou Wagner. “É um líder com provas dadas que se envolve no momento certo para promover o crescimento da Nikkiso Clean Energy & Industrial Gases para novos patamares.”

“Nunca me senti tão entusiasmado com o potencial de uma empresa como me sinto com a Nikkiso”, afirmou Ridge. “Temos todos os ingredientes certos para sermos líderes em todos os mercados que servimos em todas as regiões do mundo. Sinto–me honrado e grato por esta oportunidade única na vida.”

Sobre Adrian Ridge

Ridge juntou–se à Nikkiso Clean Energy & Industrial Gases em 2022 como EVP de Fabrico e Operações depois de ter trabalhado cerca de 30 anos na gigante sueca de fabrico Atlas Copco ocupando vários cargos de liderança global. Tem uma licenciatura em Engenharia Mecânica e um MBA da Universidade de Durham, no Reino Unido.

Contacto para os meios de comunicação social
Lisa Adams
[email protected]
Telemóvel: +1 (405) 492–1689

Sobre o Nikkiso Clean Energy & Industrial Gases Group

O Nikkiso Clean Energy & Industrial Gases Group é um fornecedor líder de equipamento criogénico, tecnologias e aplicações para os segmentos de mercado da energia limpa e dos gases industriais. O Grupo emprega mais de 1.600 pessoas em 22 países e é liderado pela Cryogenic Industries, Inc. no sul da Califórnia, EUA, a qual é uma subsidiária integral da Nikkiso Co., Ltd. (TSE: 6376).

Uma fotografia que acompanha este anúncio está disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/b3496ba9–85d1–4c91–b199–181d30747a25


GLOBENEWSWIRE (Distribution ID 9172603)

Adrian Ridge Appointed CEO of Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Calif., July 01, 2024 (GLOBE NEWSWIRE) — Effective July 1, 2024, Adrian Ridge is Chief Executive Officer of Nikkiso Clean Energy & Industrial Gases Group, part of Nikkiso Co. Ltd.’s Industrial division. Ridge succeeds Peter Wagner, who remains engaged in a Board role as Executive Chairman for Nikkiso CE&IG Group.

As CEO, Ridge will drive operational and financial results and ready the Group for future growth. In his role as Executive Chairman, Wagner will focus on driving the vision and long–term strategy of the Group in an advisor capacity.

“On behalf of the Board, I welcome and congratulate Adrian on his promotion to CEO,” said Wagner. “He is a proven leader who is engaging at the right time to support Nikkiso Clean Energy & Industrial Gases’s growth to new heights.”

“I’ve never been as excited about a company’s potential as I am about Nikkiso,” said Ridge. “We have all the right ingredients to be a leader in every market we serve in every region around the world. I am honored and grateful for this once–in–a–lifetime opportunity.”

About Adrian Ridge

Ridge joined Nikkiso Clean Energy & Industrial Gases in 2022 as EVP of Manufacturing and Operations after working approximately 30 years at Swedish manufacturing giant Atlas Copco in various global leadership roles. He has a Mechanical Engineering degree and an MBA from Durham University in the United Kingdom.

Media contact
Lisa Adams
[email protected]
Mobile: +1 (405) 492–1689

About Nikkiso Clean Energy & Industrial Gases Group

The Nikkiso Clean Energy & Industrial Gases Group is a leading provider of cryogenic equipment, technologies and applications for clean energy and industrial gas market segments. The Group employs more than 1,600 people in 22 countries and is headed by Cryogenic Industries, Inc. in Southern California, U.S., which is a wholly owned subsidiary of Nikkiso Co., Ltd. (TSE: 6376).

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b3496ba9–85d1–4c91–b199–181d30747a25


GLOBENEWSWIRE (Distribution ID 9171987)

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology–based therapies, today announced the appointment of Orlando Oliveira as its Chief Commercial Officer. With a career spanning nearly 25 years, Mr. Oliveira brings a wealth of experience building high–performing global commercial teams, driving revenue growth, and fostering strategic partnerships in the biotechnology and pharmaceutical industry.

“As we continue to advance multiple mid– to late–stage clinical development programs, we are thrilled to welcome Orlando to the Zenas leadership team,” said Joe Farmer, President and Chief Operating Officer. “His expertise and track record of building and leading high performing commercial teams will be instrumental in the establishment of the obexelimab franchise and achievement of our goal to bring obexelimab to patients worldwide. We will benefit immensely from Orlando’s broad commercial knowledge and leadership as Zenas evolves to become an integrated development and commercial biopharmaceutical company.”

“I am eager to join the seasoned executive team Zenas has built, guided by their mission to deliver transformative immunology–based therapies to patients in need,” said Mr. Oliveira. “I look forward to working with this team to further develop and execute the strategies and plans for the eventual commercialization of obexelimab and to establish Zenas as a leading global immunology–based development and commercial company.”

Prior to joining Zenas, Mr. Oliveira served as Senior Vice President & Head of International at Mirati Therapeutics (acquired by Bristol Meyers Squibb), where he helped lead and set up the international foundations of the company and prepared multiple oncology launches, including leading the European Medicines Agency approval of KRAZATI®. Previously, he served as Senior Vice President & General Manager International at Agios Pharmaceuticals (oncology business acquired by Servier), and in the same capacity at TESARO (acquired by GlaxoSmithKline). Previously, he served as Vice President Europe & Intercontinental Operations at Cubist Pharmaceuticals (acquired by Merck). Mr. Oliveira also held, during more than a decade, numerous roles of increasing responsibility at Amgen. Mr. Oliveira currently serves as a Board member at OncoInvent AS, a privately held clinical–stage radiopharmaceutical company. He obtained a degree in Pharmacy and a post–graduate degree in Drug and Pharmacy Law from the University of Coimbra, Portugal.

About Zenas BioPharma

Zenas BioPharma is a clinical–stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology–based therapies for patients in need. With clinical development capabilities and operations globally, Zenas is advancing a portfolio of potentially differentiated autoimmune therapeutics in areas of high unmet medical need. Zenas’ experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on X at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Argot Partners
[email protected]


GLOBENEWSWIRE (Distribution ID 9171428)